- Home
- ALDX vs FUND Comparison
ALDX vs FUND Comparison
Compare ALDX & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FUND
- Stock Information
- Founded
- ALDX 2004
- FUND 1988
- Country
- ALDX United States
- FUND Canada
- Employees
- ALDX N/A
- FUND N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FUND Investment Managers
- Sector
- ALDX Health Care
- FUND Finance
- Exchange
- ALDX Nasdaq
- FUND Nasdaq
- Market Cap
- ALDX 296.0M
- FUND 245.4M
- IPO Year
- ALDX 2014
- FUND N/A
- Fundamental
- Price
- ALDX $4.72
- FUND $8.18
- Analyst Decision
- ALDX Strong Buy
- FUND
- Analyst Count
- ALDX 2
- FUND 0
- Target Price
- ALDX $9.50
- FUND N/A
- AVG Volume (30 Days)
- ALDX 625.1K
- FUND 32.5K
- Earning Date
- ALDX 11-05-2025
- FUND 01-01-0001
- Dividend Yield
- ALDX N/A
- FUND 6.64%
- EPS Growth
- ALDX N/A
- FUND N/A
- EPS
- ALDX N/A
- FUND 0.93
- Revenue
- ALDX N/A
- FUND N/A
- Revenue This Year
- ALDX N/A
- FUND N/A
- Revenue Next Year
- ALDX $63.48
- FUND N/A
- P/E Ratio
- ALDX N/A
- FUND $8.33
- Revenue Growth
- ALDX N/A
- FUND N/A
- 52 Week Low
- ALDX $1.14
- FUND $6.75
- 52 Week High
- ALDX $7.20
- FUND $8.47
- Technical
- Relative Strength Index (RSI)
- ALDX 34.90
- FUND 42.42
- Support Level
- ALDX $4.85
- FUND $8.12
- Resistance Level
- ALDX $5.27
- FUND $8.26
- Average True Range (ATR)
- ALDX 0.27
- FUND 0.12
- MACD
- ALDX -0.05
- FUND -0.03
- Stochastic Oscillator
- ALDX 14.15
- FUND 16.22
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.